BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16495248)

  • 1. Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae.
    Bogdanovich T; Bozdogan B; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Mar; 50(3):893-8. PubMed ID: 16495248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates.
    Peric M; Bozdogan B; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1017-22. PubMed ID: 12604536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
    Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin.
    Fuchs PC; Barry AL; Brown SD
    J Clin Microbiol; 2001 Jan; 39(1):43-6. PubMed ID: 11136745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations.
    De Vecchi E; Nicola L; Larosa M; Drago L
    BMC Microbiol; 2008 Jan; 8():23. PubMed ID: 18230154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides.
    Drago L; De Vecchi E; Nicola L; Colombo A; Gismondo MR
    J Antimicrob Chemother; 2004 Aug; 54(2):542-5. PubMed ID: 15215227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli.
    Cagliero C; Mouline C; Payot S; Cloeckaert A
    J Antimicrob Chemother; 2005 Nov; 56(5):948-50. PubMed ID: 16157618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic bactericidal activity of telithromycin, azithromycin and clarithromycin against respiratory pathogens.
    Drago L; De Vecchi E; Nicola L; Legnani D; Gismondo MR
    APMIS; 2005 Oct; 113(10):655-63. PubMed ID: 16309423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of five quinolones, three macrolides and telithromycin against 12 Haemophilus influenzae strains with different resistance phenotypes.
    Pankuch GA; Lin G; Appelbaum PC
    Clin Microbiol Infect; 2005 Dec; 11(12):1040-4. PubMed ID: 16307562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of carbon dioxide on the susceptibility of key respiratory tract pathogens to telithromycin and azithromycin.
    Bouchillon SK; Johnson JL; Hoban DJ; Stevens TM; Johnson BM
    J Antimicrob Chemother; 2005 Jul; 56(1):224-7. PubMed ID: 15890718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inability of L22 ribosomal protein alteration to increase macrolide MICs in the absence of efflux mechanism in Haemophilus influenzae HMC-S.
    Peric M; Bozdogan B; Galderisi C; Krissinger D; Rager T; Appelbaum PC
    J Antimicrob Chemother; 2004 Aug; 54(2):393-400. PubMed ID: 15243030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin.
    Clark C; Bozdogan B; Peric M; Dewasse B; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2956-62. PubMed ID: 12183253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [in vitro activity of telithromycin against Haemophilus influenzae].
    Dabernat H; Seguy M; Delmas C
    Pathol Biol (Paris); 2002 Feb; 50(1):58-62. PubMed ID: 11873632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A time-kill evaluation of clarithromycin and azithromycin against two extracellular pathogens and the development of resistance.
    Burgess DS; Hastings RW; Horan JL
    Ann Pharmacother; 1999 Dec; 33(12):1262-5. PubMed ID: 10630825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary.
    Zhanel GG; Johanson C; Laing N; Hisanaga T; Wierzbowski A; Hoban DJ
    Antimicrob Agents Chemother; 2005 May; 49(5):1943-8. PubMed ID: 15855517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22.
    Reinert RR; Al-Lahham A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3011-3. PubMed ID: 15980387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.